121 related articles for article (PubMed ID: 31669165)
1. [Eleven years of economic evaluations of medical devices by the Spanish Network of Assessment Agencies. Methodological quality and cost-utility impact].
Giménez E; García-Pérez L; Márquez S; Gutiérrez MA; Bayón JC; Espallargues M
Gac Sanit; 2020; 34(4):326-333. PubMed ID: 31669165
[TBL] [Abstract][Full Text] [Related]
2. The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS).
Serrano-Aguilar P; Asua-Batarrita J; Molina-López MT; Espallargues M; Pons-Rafols J; García-Armesto S; Arriola-Bolado P; López-García M; Faraldo-Vallés MJ; Sánchez-Gómez LM; Juárez-Rojo C; Prieto-Yerro I; Casado-Durández P; Sarria-Santamera A
Int J Technol Assess Health Care; 2019 Jan; 35(3):176-180. PubMed ID: 31006412
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
4. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
[TBL] [Abstract][Full Text] [Related]
5. Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs.
Ghabri S; Lam L; Bocquet F; Spath HM
Pharmacoeconomics; 2020 May; 38(5):459-471. PubMed ID: 32052376
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review.
Ruger JP; Emmons KM
Value Health; 2008; 11(2):180-90. PubMed ID: 17854435
[TBL] [Abstract][Full Text] [Related]
7. From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review.
Ku Abd Rahim KN; Kamaruzaman HF; Dahlui M; Wan Puteh SE
Value Health Reg Issues; 2020 May; 21():91-99. PubMed ID: 31698173
[TBL] [Abstract][Full Text] [Related]
8. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and quality assessment of economic evaluation studies of injury prevention.
Polinder S; Segui-Gomez M; Toet H; Belt E; Sethi D; Racioppi F; van Beeck EF
Accid Anal Prev; 2012 Mar; 45():211-21. PubMed ID: 22269503
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics Evaluations of Oral Anticancer Agents: Systematic Review of Characteristics, Methodological Trends, and Reporting Quality.
Al Kadour A; Marridi WA; Al-Badriyeh D
Value Health Reg Issues; 2018 Sep; 16():46-60. PubMed ID: 30144775
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?
Aguiar PM; Lima TM; Storpirtis S
J Clin Pharm Ther; 2016 Apr; 41(2):189-97. PubMed ID: 27009796
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the quality and scope of economic evaluations in child oral health research.
Rogers HJ; Rodd HD; Vermaire JH; Stevens K; Knapp R; El Yousfi S; Marshman Z
BMC Oral Health; 2019 Jul; 19(1):132. PubMed ID: 31262293
[TBL] [Abstract][Full Text] [Related]
13. Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil.
Campolina AG; Rozman LM; Decimoni TC; Leandro R; Novaes HM; De Soárez PC
Appl Health Econ Health Policy; 2017 Apr; 15(2):163-172. PubMed ID: 27798797
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.
Jäkel A; Plested M; Dharamshi K; Modha R; Bridge S; Johns A
Appl Health Econ Health Policy; 2013 Feb; 11(1):27-43. PubMed ID: 23329379
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluations in water-fluoridation: a scoping review.
Mariño R; Zaror C
BMC Oral Health; 2020 Apr; 20(1):115. PubMed ID: 32299417
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
[TBL] [Abstract][Full Text] [Related]
17. Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review.
Bouée-Benhamiche E; Bousquet PJ; Ghabri S
Appl Health Econ Health Policy; 2020 Aug; 18(4):491-508. PubMed ID: 32056121
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature.
Skally M; Hanly P; Sharp L
Appl Health Econ Health Policy; 2013 Jun; 11(3):181-92. PubMed ID: 23549792
[TBL] [Abstract][Full Text] [Related]
19. Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: adaptación al español de la lista de comprobación CHEERS 2022.
Augustovski F; García Martí S; Espinoza MA; Palacios A; Husereau D; Pichon-Riviere A
Value Health Reg Issues; 2022; 27():110-114. PubMed ID: 35031081
[TBL] [Abstract][Full Text] [Related]
20. Economic Evaluations of Pathology Tests, 2010-2015: A Scoping Review.
Watts RD; Li IW; Geelhoed EA; Sanfilippo FM; St John A
Value Health; 2017 Sep; 20(8):1210-1215. PubMed ID: 28964454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
